IN2015KN00222A - - Google Patents

Info

Publication number
IN2015KN00222A
IN2015KN00222A IN222KON2015A IN2015KN00222A IN 2015KN00222 A IN2015KN00222 A IN 2015KN00222A IN 222KON2015 A IN222KON2015 A IN 222KON2015A IN 2015KN00222 A IN2015KN00222 A IN 2015KN00222A
Authority
IN
India
Prior art keywords
silybin
mayer
phospholipids
mixed
disclosed
Prior art date
Application number
Inventor
Ezio Bombardelli
Fabrizio Corti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of IN2015KN00222A publication Critical patent/IN2015KN00222A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Disclosed are compositions containing extracts of (a) panax ginseng C.A. Mayer, (b) Zingiber officinale,(c) Echinacea angustifolia and (d) Silybum marianum or the phospholipid complex of silybin with phospholipids as active ingredients, mixed with suitable excipients.
IN222KON2015 2012-07-27 2013-07-11 IN2015KN00222A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001317A ITMI20121317A1 (en) 2012-07-27 2012-07-27 COMPOSITIONS FOR THE TREATMENT OF ONCOLOGICAL FATIGUE
PCT/EP2013/064711 WO2014016137A1 (en) 2012-07-27 2013-07-11 Compositions for treatment of cancer-related fatigue

Publications (1)

Publication Number Publication Date
IN2015KN00222A true IN2015KN00222A (en) 2015-06-12

Family

ID=46939795

Family Applications (1)

Application Number Title Priority Date Filing Date
IN222KON2015 IN2015KN00222A (en) 2012-07-27 2013-07-11

Country Status (22)

Country Link
US (1) US9566309B2 (en)
EP (1) EP2877192B1 (en)
JP (1) JP6129314B2 (en)
KR (1) KR102091128B1 (en)
CN (1) CN104540514B (en)
AU (1) AU2013295227B2 (en)
BR (1) BR112015001174B1 (en)
CA (1) CA2879906A1 (en)
DK (1) DK2877192T3 (en)
ES (1) ES2590209T3 (en)
HK (1) HK1209375A1 (en)
HR (1) HRP20160774T1 (en)
HU (1) HUE030002T2 (en)
IL (1) IL236871B (en)
IN (1) IN2015KN00222A (en)
IT (1) ITMI20121317A1 (en)
PL (1) PL2877192T3 (en)
PT (1) PT2877192T (en)
RU (1) RU2631612C2 (en)
SG (1) SG11201500521XA (en)
SI (1) SI2877192T1 (en)
WO (1) WO2014016137A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3040078T3 (en) * 2013-08-30 2021-11-02 Green Cross Wellbeing Corporation Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent
CA3005700A1 (en) * 2015-12-16 2017-06-22 Vivek Anand PARACHUR Tri-molecular complex of natural compounds
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
WO2022245923A1 (en) 2021-05-18 2022-11-24 Prostasis, Llc Compositions comprising mixtures of compounds and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215291B (en) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa FLAVANOLIGNANI COMPLEXES WITH PHOSPHOLIPIDS, THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
EP0464298B1 (en) 1990-07-05 1995-06-21 INDENA S.p.A. Echinacea extracts, a process for the preparation thereof and formulations containing them
CZ292832B6 (en) * 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Process for preparing silymarin exhibiting increased solubility
US20030206978A1 (en) * 2001-11-29 2003-11-06 Bob Sherwood Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
EP1613206A2 (en) * 2003-04-16 2006-01-11 The University Of Mississippi Immunostimulatory agents in botanicals
US20050031710A1 (en) * 2003-08-08 2005-02-10 D'adamo Peter James Method of personal care and cosmetic product preparation and composition using human blood type
RU2277927C2 (en) * 2004-09-15 2006-06-20 Наталья Ивановна Весельева Therapeutical and prophylactic complex "balsam dolgoletie" (balsam longevity) producing generally restorative and tonic effects
ITMI20090049A1 (en) * 2009-01-20 2010-07-21 Indena Spa COMPOSITIONS BASED ON LIPOFILE EXTRACTS OF ZINGIBER OFFICINALE AND ECHINACEA ANGUSTIFOLIA FOR THE PREVENTION AND TREATMENT OF GASTRO-ESOPHAGEAL REFLOW AND CHEMOTHERAPY-INDUCED EMESIS
CN101502320B (en) * 2009-03-11 2012-09-05 王越 Method for producing ginseng ginger red date drink
IT1401141B1 (en) * 2010-07-26 2013-07-12 Indena Spa FORMULATIONS CONTAINING EXTRACTS OF ECHINACEA ANGUSTIFOLIA AND ZINGIBER OFFICINALE USEFUL IN THE REDUCTION OF INFLAMMATION AND PERIPHERAL PAIN

Also Published As

Publication number Publication date
ITMI20121317A1 (en) 2014-01-28
US20150202246A1 (en) 2015-07-23
AU2013295227A1 (en) 2015-02-19
EP2877192B1 (en) 2016-06-08
KR102091128B1 (en) 2020-03-20
BR112015001174A2 (en) 2017-06-27
JP2015522631A (en) 2015-08-06
RU2631612C2 (en) 2017-09-25
SI2877192T1 (en) 2016-09-30
CN104540514A (en) 2015-04-22
HUE030002T2 (en) 2017-04-28
PT2877192T (en) 2016-09-13
CN104540514B (en) 2020-03-27
SG11201500521XA (en) 2015-02-27
RU2015102002A (en) 2016-09-20
PL2877192T3 (en) 2016-12-30
BR112015001174B1 (en) 2021-02-02
HK1209375A1 (en) 2016-04-01
WO2014016137A1 (en) 2014-01-30
US9566309B2 (en) 2017-02-14
JP6129314B2 (en) 2017-05-17
ES2590209T3 (en) 2016-11-18
DK2877192T3 (en) 2016-09-05
KR20150037890A (en) 2015-04-08
EP2877192A1 (en) 2015-06-03
CA2879906A1 (en) 2014-01-30
AU2013295227B2 (en) 2017-04-27
IL236871B (en) 2018-01-31
HRP20160774T1 (en) 2016-08-12

Similar Documents

Publication Publication Date Title
CA2956871C (en) Compounds active towards bromodomains
BR112015023629A8 (en) ABIRATERONE ACETATE FORMULATION
WO2012174158A3 (en) Administration of benzodiazepine
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2012050396A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating liver cancer
MX2018000546A (en) Pharmaceutical composition containing celecoxib and tramadol.
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
WO2014137797A3 (en) Stable glucokinase activator compositions
IN2015KN00222A (en)
WO2012050398A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer
EA201590571A1 (en) COMPOSITIONS BASED ON PLANTS
WO2013175504A3 (en) Herbal composition for vaginal treatment
IN2015DN02944A (en)
CO2018004665A2 (en) Oxadiazoespiric compounds
WO2013170086A3 (en) Formulations for the delivery of active ingredients
MX2018014790A (en) Combination formulation of three antiviral compounds.
ES2325291A1 (en) Use of a silybum marianum extract
MX2021003908A (en) Long-acting polypeptides and methods of producing and administering same.
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
PH12018000227B1 (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
HK1204967A1 (en) Composition containing natural plant extracts as active ingredients, external skin preparation comprising the same, cosmetic preparation comprising the same and pharmaceutical preparation comprising the same
MX360308B (en) Combinations of extracts of serenoa repens and lipophilic extracts of zingiber officinalis and echinacea angustifolia, the use thereof, and formulations containing them.
MX2016004094A (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide.
PH12018500682A1 (en) Oxa-diazaspiro compounds having activity against pain
PH12017501979A1 (en) Pharmaceutical compound